Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Pediatric Nephrology
Erschienen in: Pediatric Nephrology 3/2008

01.03.2008 | Original Article

The influence of urinary flow rate in children on excretion of markers used for assessment of renal damage: albumin, γ-glutamyl transpeptidase, N-acetyl-β-D-glucosaminidase, and alpha1-microglobulin

verfasst von: Felicia Trachtenberg, Lars Barregard, Sonja McKinlay

Erschienen in: Pediatric Nephrology | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Abstract

The aim of the present study was to examine the influence of urinary flow rate on markers of renal function in children. A sub-study of the New England Children’s Amalgam Trial collected 82 pairs of urine samples from children aged 10–16 years: a timed overnight collection and a spot daytime sample collected the following day. These samples were analyzed for albumin, γ-glutamyl transpeptidase (γ-GT), N-acetyl-β-D-glucosaminidase (NAG), alpha1-microglobulin (A1M), and creatinine concentration. Regression analysis was used to model the effect of urinary flow rate in the timed overnight samples. A paired t-test compared concentrations and creatinine-corrected renal markers between overnight and daytime samples. Albumin, γ-GT, NAG, and A1M excretion rates increased significantly with urinary flow rate. Their corresponding creatinine-corrected markers did not vary significantly with urinary flow rate, but the creatinine-corrected excretions of albumin, γ-GT, and NAG were significantly higher in daytime samples than in overnight samples, with the same (non-significant) trend for A1M. The influence of urinary flow rate on creatinine-corrected markers of renal function was markedly less than its influence on excretion rates. Therefore, the use of creatinine-corrected markers seems to be a good choice in practice, with the caveat that daytime and overnight samples are not comparable.
Literatur
1.
World Health Organization (WHO) (2003) Concise international chemical assessment document 50. Elemental mercury and inorganic mercury compounds: human health aspects. WHO, Geneva
2.
Cardenas A, Roels H, Bernard AM, Barbon R, Buchet JP, Lauwerys RR, Rosello J, Hotter G, Mutti A, Franchini I, Fels LM, Stolte H, De Broe ME, Nuyts GD, Taylor SA, Price RG (1993) Markers of early renal changes induced by industrial pollutants. I. Application to workers exposed to mercury vapour. Br J Ind Med 50:17–27PubMed
3.
Boeniger MF, Lowry LK, Rosenberg J (1993) Interpretation of urine results used to assess chemical exposure with emphasis on creatinine adjustments: a review. Am Ind Hyg Assoc J 54:615–627PubMed
4.
Araki S, Aono H, Murata K (1986) Adjustment of urinary concentration to urinary volume in relation to erythrocyte and plasma concentrations: an evaluation of urinary heavy metals and organic substances. Arch Environ Health 41:171–177PubMedCrossRef
5.
Greenberg GN, Levine RJ (1989) Urinary creatinine excretion is not stable: a new method for assessing urinary toxic substance concentrations. J Occup Med 31:832–838PubMedCrossRef
6.
Araki S, Aono H (1989) Effects of water restriction and water loading on daily urinary excretion of heavy metals and organic substances in metal workers. Br J Ind Med 46:389–392PubMed
7.
Viberti GC, Mogensen CE, Keen H, Jacobsen FK, Jarrett RJ, Christensen CK (1982) Urinary excretion of albumin in normal man: the effect of water loading. Scand J Clin Lab Invest 42:147–157PubMedCrossRef
8.
Jespersen B, Pedersen EB, Danielsen H, Kornerup HJ, Knudsen F, Mogensen CE, Nielsen AH (1986) Urinary excretion of albumin and beta-2-microglobulin in hypertensive and normotensive renal transplant recipients during urinary diluting and concentrating tests. Scand J Clin Lab Invest 46:609–614PubMedCrossRef
9.
Jung K, Schulze G (1986) Diuresis-dependent excretion of multiple forms of renal brush-border enzymes in urine. Clin Chim Acta 156:77–83PubMedCrossRef
10.
Jung K, Schulze G, Reinholdt C (1986) Different diuresis-dependent excretions of urinary enzymes: N-acetyl-beta-D-glucosaminidase, alanine aminopeptidase, alkaline phosphatase, and gamma-glutamyltransferase. Clin Chem 32:529–532PubMed
11.
Wellwood JM, Ellis BG, Price RG, Hammond K, Thompson AE, Jones NF (1975) Urinary N-acetyl- beta-D-glucosaminidase activities in patients with renal disease. Br Med J 3:408–411PubMedCrossRef
12.
Harding S, Munro AJ (1978) Frusemide and renal enzyme excretion. Br Med J 2:1431PubMed
13.
Guarnieri G, Ianche M, Lin S (1979) Renal enzyme and protein excretion after induction of a diuresis. Br Med J 2:50–51PubMed
14.
Lockwood TD, Bosmann HB (1979) The use of urinary N-acetyl-beta-glucosaminidase in human renal toxicology. I. Partial biochemical characterization and excretion in humans and release from the isolated perfused rat kidney. Toxicol Appl Pharmacol 49:323–336PubMedCrossRef
15.
Houser MT (1986) The effect of hydropenia and oral water loading on renal lysozyme handling and N-acetyl-beta-D-glucosaminidase excretion in man. Ann Clin Biochem 23:453–457PubMed
16.
Eshoj O, Feldt-Rasmussen B, Larsen ML, Mogensen EF (1987) Comparison of overnight, morning and 24-hour urine collections in the assessment of diabetic microalbuminuria. Diabet Med 4:531–533PubMed
17.
Davies AG, Postlethwaite RJ, Price DA, Burn JL, Houlton CA, Fielding BA (1984) Urinary albumin excretion in school children. Arch Dis Child 59:625–630PubMed
18.
Zuppi C, Baroni S, Scribano D, Di Salvo S, Musumeci V (1995) Choice of time for urine collection for detecting early kidney abnormalities in hypertensives. Ann Clin Biochem 32:373–378PubMed
19.
Chachati A, von Frenckell R, Foidart-Willems J, Godon JP, Lefebvre PJ (1987) Variability of albumin excretion in insulin-dependent diabetics. Diabet Med 4:441–445PubMed
20.
Vestbo E, Damsgaard EM, Froland A, Mogensen CE (1995) Urinary albumin excretion in a population based cohort. Diabet Med 12:488–493PubMed
21.
Feldmann D, Flandrois C, Jardel A, Phan TM, Aymard P (1989) Circadian variations and reference intervals for some enzymes in urine of healthy children. Clin Chem 35:864–867PubMed
22.
Lakatua DJ, Blomquist CH, Haus E, Sackett-Lundeen L, Berg H, Swoyer J (1982) Circadian rhythm in urinary N-acetyl-beta-glucosaminidase (NAG) of clinically healthy subjects. Timing and phase relation to other urinary circadian rhythms. Am J Clin Pathol 78:69–77
23.
Cundy TF, Nixon D, Berkahn L, Baker J (1992) Measuring the albumin excretion rate: agreement between methods and biological variability. Diabet Med 9:138–143PubMed
24.
Bellinger DC, Trachtenberg F, Barregard L, Tavares M, Cernichiari E, Daniel D, McKinlay S (2006) Neuropsychological and renal effects of dental amalgam in children: a randomized clinical trial. JAMA 295:1775–1783PubMedCrossRef
25.
Children’s Amalgam Trial Study Group (2003) The Children’s Amalgam Trial: design and methods. Control Clin Trials 24:795–814
26.
Jarup L, Hellstrom L, Alfven T, Carlsson MD, Grubb A, Persson B, Pettersson C, Spang G, Schütz A, Elinder CG (2000) Low level exposure to cadmium and early kidney damage: the OSCAR study. Occup Environ Med 57:668–672PubMedCrossRef
27.
Sanchez-Bayle M, Rodriguez-Cimadevilla C, Asensio C, Ruiz-Jarabo C, Baena J, Arnaiz P, Villa S, Cocho P (1995) Urinary albumin excretion in Spanish children. Nino Jesus Group. Pediatr Nephrol 9:428–430PubMedCrossRef
28.
Bangstad HJ, Dahl-Jorgensen K, Kjaersgaard P, Mevold K, Hanssen KF (1993) Urinary albumin excretion rate and puberty in non-diabetic children and adolescents. Acta Paediatr 82:857–862PubMed
29.
Lorini R, d’Annunzio G, Vitali L, Scaramuzza A, Bacchella L, Zonta LA (1998) Normal values of overnight albumin excretion rate in a sample of healthy Italian children and adolescents. J Pediatr Endocrinol Metab 11:639–643PubMed
30.
Hjorth L, Helin I, Grubb A (2000) Age-related reference limits for urine levels of albumin, orosomucoid, immunoglobulin G and protein HC in children. Scand J Clin Lab Invest 60:65–73PubMedCrossRef
31.
Lehrnbecher T, Greissinger S, Navid F, Pfuller H, Jeschke R (1998) Albumin, IgG, retinol-binding protein, and alpha1-microglobulin excretion in childhood. Pediatr Nephrol 12:290–292PubMedCrossRef
32.
Oba K, Hirai M, Ajiro Y, Okazaki K, Sato S, Sasai K, Suzuki T, Nakano H, Metori S (1999) Effect of age on urinary excretion of N-acetyl-beta-D-glucosaminidase. Nippon Ika Daigaku Zasshi 66:33–36PubMedCrossRef
33.
Osborne J (1980) Urinary excretion of N-acetyl-beta-d-glucosaminidase in children. Arch Dis Child 55:719–721PubMed
34.
Remer T, Neubert A, Maser-Gluth C (2002) Anthropometry-based reference values for 24-h urinary creatinine excretion during growth and their use in endocrine and nutritional research. Am J Clin Nutr 75:561–569PubMed
35.
Goldwasser P, Aboul-Magd A, Maru M (1997) Race and creatinine excretion in chronic renal insufficiency. Am J Kidney Dis 30:16–22PubMed
36.
Agirbasli M, Radhakrishnamurthy B, Jiang X, Bao W, Berenson GS (1996) Urinary N-acetyl-beta-D-glucosaminidase changes in relation to age, sex, race, and diastolic and systolic blood pressure in a young adult biracial population. The Bogalusa Heart Study. Am J Hypertens 9:157–161PubMedCrossRef
37.
Jones CA, Francis ME, Eberhardt MS, Chavers B, Coresh J, Engelgau M, Kusek JW, Byrd-Holt D, Narayan KM, Herman WH, Jones CP, Salive M, Aodoa LY (2002) Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis 39:445–459PubMed
38.
Jung K, Hempel A, Grutzmann KD, Hempel RD, Schreiber G (1990) Age-dependent excretion of alanine aminopeptidase, alkaline phosphatase, gamma-glutamyltransferase and N-acetyl-beta-D-glucosaminidase in human urine. Enzyme 43:10–16PubMed
39.
Skinner AM, Addison GM, Price DA (1996) Changes in the urinary excretion of creatinine, albumin and N-acetyl-beta-D-glucosaminidase with increasing age and maturity in healthy schoolchildren. Eur J Pediatr 155:596–602PubMed
40.
Bakker AJ (1999) Detection of microalbuminuria. Receiver operating characteristic curve analysis favors albumin-to-creatinine ratio over albumin concentration. Diabetes Care 22:307–313PubMedCrossRef
41.
Jung K, Pergande M (1992) Sex- and age-dependent reference values of alpha-1-microglobulin in urine. Nephron 62:474–475PubMed
42.
Kesteloot H, Joossens JV (1996) On the determinants of the creatinine clearance: a population study. J Hum Hypertens 10:245–249PubMed
43.
Tencer J, Thysell H, Grubb A (1996) Analysis of proteinuria: reference limits for urine excretion of albumin, protein HC, immunoglobulin G, kappa- and lambda-immunoreactivity, orosomucoid and alpha 1-antitrypsin. Scand J Clin Lab Invest 56:691–700PubMedCrossRef
44.
Harvey JN, Hood K, Platts JK, Devarajoo S, Meadows PA (1999) Prediction of albumin excretion rate from albumin-to-creatinine ratio. Diabetes Care 22:1597–1598PubMedCrossRef
45.
Jacobs DR Jr, Murtaugh MA, Steffes M, Yu X, Roseman J, Goetz FC (2002) Gender- and race-specific determination of albumin excretion rate using albumin-to-creatinine ratio in single, untimed urine specimens: The Coronary Artery Risk Development in Young Adults Study. Am J Epidemiol 155:1114–1119PubMedCrossRef
46.
Mattix HJ, Hsu CY, Shaykevich S, Curhan G (2002) Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race. J Am Soc Nephrol 13:1034–1039PubMed
47.
Lindeman RD, Romero L, Liang HC, Hundley R, Baumgartner R, Koehler K, Garry P (1998) Prevalence of proteinuria/microalbuminuria in an elderly urban, biethnic community. Geriatr Nephrol Urol 8:123–130PubMedCrossRef
48.
Metcalf PA, Baker JR, Scragg RK, Dryson E, Scott AJ, Wild CJ (1993) Microalbuminuria in a middle-aged workforce. Effect of hyperglycemia and ethnicity. Diabetes Care 16:1485–1493PubMedCrossRef
49.
Summerson JH, Bell RA, Konen JC (1995) Racial differences in the prevalence of microalbuminuria in hypertension. Am J Kidney Dis 26:577–579PubMed
50.
Hara F, Nakazato K, Shiba K, Shimoda J, Kojima T, Fukumura Y, Kobayashi I (1994) Studies of diabetic nephropathy. I. Effects of storage time and temperature on microalbuminuria. Biol Pharm Bull 17:1241–1245PubMed
51.
Loeb WF, Das SR, Trout JR (1997) The effect of erythritol on the stability of gamma-glutamyl transpeptidase and N-acetyl glucosaminidase in human urine. Toxicol Pathol 25:264–267PubMed
52.
Manley SE, Burton ME, Fisher KE, Cull CA, Turner RC (1992) Decreases in albumin/creatinine and N-acetylglucosaminidase/creatinine ratios in urine samples stored at −20 degrees C. Clin Chem 38:2294–2299PubMed
53.
Matteucci E, Gregori G, Pellegrini L, Navalesi R, Giampietro O (1991) How can storage time and temperature affect enzymic activities in urines? Enzyme 45:116–120PubMed
54.
Matteucci E, Pellegrini L, Uncini-Manganelli C, Cecere M, Saviozzi M, Giampietro O (1992) More on effects of storage time and temperature on urinary enzymes: a 1-year study. Enzyme 46:249–251PubMed
55.
Osberg I, Chase HP, Garg SK, DeAndrea A, Harris S, Hamilton R, Marshall G (1990) Effects of storage time and temperature on measurement of small concentrations of albumin in urine. Clin Chem 36:1428–1430PubMed
56.
Schultz CJ, Dalton RN, Turner C, Neil HA, Dunger DB (2000) Freezing method affects the concentration and variability of urine proteins and the interpretation of data on microalbuminuria. The Oxford Regional Prospective Study Group. Diabet Med 17:7–14PubMedCrossRef
57.
Shield JP, Hunt LP, Morgan JE, Pennock CA (1995) Are frozen urine samples acceptable for estimating albumin excretion in research? Diabet Med 12:713–716PubMedCrossRef
58.
Tencer J, Thysell H, Andersson K, Grubb A (1994) Stability of albumin, protein HC, immunoglobulin G, kappa- and lambda-chain immunoreactivity, orosomucoid and alpha 1-antitrypsin in urine stored at various conditions. Scand J Clin Lab Invest 54:199–206PubMedCrossRef
59.
Tencer J, Thysell H, Andersson K, Grubb A (1997) Long-term stability of albumin, protein HC, immunoglobulin G, kappa- and lambda-chain-immunoreactivity, orosomucoid and alpha 1-antitrypsin in urine stored at −20 degrees C. Scand J Urol Nephrol 31:67–71PubMedCrossRef
60.
MacNeil ML, Mueller PW, Caudill SP, Steinberg KK (1991) Considerations when measuring urinary albumin: precision, substances that may interfere, and conditions for sample storage. Clin Chem 37:2120–2123PubMed
61.
Klasen IS, Reichert LJ, de Kat Angelino CM, Wetzels JF (1999) Quantitative determination of low and high molecular weight proteins in human urine: influence of temperature and storage time. Clin Chem 45:430–432PubMed
62.
Grogan CB, Ekvall SM (1999) Body composition of children with myelomeningocele, determined by 40K, urinary creatinine and anthropometric measures. J Am Coll Nutr 18:316–323PubMed
63.
Forbes GB, Bruining GJ (1976) Urinary creatinine excretion and lean body mass. Am J Clin Nutr 29:1359–1366PubMed
64.
Ebner A, Manz F (2002) Sex difference of urinary osmolality in German children. Am J Nephrol 22:352–355PubMedCrossRef
65.
66.
Hogg RJ, Portman RJ, Milliner D, Lemley KV, Eddy A, Ingelfinger J (2000) Evaluation and management of proteinuria and nephrotic syndrome in children: recommendations from a pediatric nephrology panel established at the National Kidney Foundation conference on proteinuria, albuminuria, risk, assessment, detection, and elimination (PARADE). Pediatrics 105:1242–1249PubMedCrossRef
67.
Basturk T, Altuntas Y, Kurklu A, Aydin L, Eren N, Unsal A (2006) Urinary N-acetyl B glucosaminidase as an earlier marker of diabetic nephropathy and influence of low-dose perindopril/indapamide combination. Ren Fail 28:125–128PubMedCrossRef
68.
Gibb DM, Shah V, Preece M, Barratt TM (1989) Variability of urine albumin excretion in normal and diabetic children. Pediatr Nephrol 3:414–419PubMedCrossRef
69.
Skinner AM, Clayton PE, Price DA, Addison GM, Mui CY (1993) Variability in the urinary excretion of growth hormone in children: a comparison with other urinary proteins. J Endocrinol 138:337–343PubMed
70.
Gaspari F, Perico N, Remuzzi G (2006) Timed urine collections are not needed to measure urine protein excretion in clinical practice. Am J Kidney Dis 47:1–7PubMedCrossRef
71.
Shidham G, Hebert LA (2006) Timed urine collections are not needed to measure urine protein excretion in clinical practice. Am J Kidney Dis 47:8–14PubMedCrossRef
Metadaten
Titel
The influence of urinary flow rate in children on excretion of markers used for assessment of renal damage: albumin, γ-glutamyl transpeptidase, N-acetyl-β-D-glucosaminidase, and alpha1-microglobulin
verfasst von
Felicia Trachtenberg
Lars Barregard
Sonja McKinlay
Publikationsdatum
01.03.2008
Verlag
Springer-Verlag
Erschienen in
Pediatric Nephrology / Ausgabe 3/2008
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-007-0568-1

Weitere Artikel der Ausgabe 3/2008

Pediatric Nephrology 3/2008 Zur Ausgabe

Editorial Commentary

Discrepancies in office and ambulatory blood pressure in adolescents: help or hindrance?

Original Article

Rituximab therapy for juvenile-onset systemic lupus erythematosus

Brief Report

Arterial thrombosis associated with factor V Leiden and methylenetetrahydrofolate reductase C677T mutation in childhood membranous glomerulonephritis

Review

Insulin and its role in chronic kidney disease

Original Article

Automated peritoneal dialysis as the modality of choice: a single-center, 3-year experience with 458 children in Mexico

Original Article

Expression of mRNA for functional molecules in urinary sediment in glomerulonephritis

Neu im Fachgebiet Pädiatrie

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

16.05.2024 Arterielle Hypertonie in der Pädiatrie Nachrichten

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise